pISSN:1309 - 6958       eISSN:2146 - 1953
2021, Cilt 37, Sayı 3, Sayfa(lar) 202-208
Mitigation of the biosafety risks of SARS-CoV-2 at BSL-3 laboratories
Mustafa Sencer Karagül1, Orbay Sayı2, Mevlüt Demirbaş3, Fahriye Saraç4, Mustafa Hasöksüz5
1Kocaeli University, Vocational School of Equine Science, Kocaeli, Turkey
2Pendik Veterinary Control Institute, Bacteriological Diagnosis Laboratory, Istanbul, Turkey
3Pendik Veterinary Control Institute, Drug Quality Control Laboratory, Istanbul, Turkey
4Pendik Veterinary Control Institute, Viral Vaccine Production Laboratory, Istanbul, Turkey
5Istanbul University Cerrahpasa, Veterinary Faculty, Department of Virology, Istanbul, Turkey
Keywords: Biorisk, biosafety, BSL-3, risk assessment, SARS-CoV-2
Downloaded:45 - Viewed: 85

Aim: The aim of this study is to reduce the biosafety risks of laboratory exhaust air due to SARS-CoV-2 at a biosafety level-3 laboratory used for vaccine development against COVID-19 pandemic.

Materials and Methods: In this study, the infrastructure and the organisation of the containment laboratory, which aimed to be used to struggle with pandemic, was used for risk assessment. Assessment of the laboratory exhaust air procedure as a component of the heating-ventilation-air conditioning system, which is significant for high-level biosafety laboratories, was conducted through a risk assessment matrix.

Results: A heating system providing exhaust air exposure to heat at 90 C° before being discharged to the outside was selected as the risk mitigation strategy after the risk analysis. The system was established as an additional biosafety barrier before the discharge of laboratory exhaust air passing through high-efficiency particulate filters. The biosafety barriers provide a safer working environment by reducing the biological risk stemming from the laboratory work. It also strengthens the existing biosafety status by building a novel and extra biosafety barrier between the laboratory and the outside environment. The residual risk was reduced to an acceptable level with the help of an additional mitigation measure regarding reassessment.

Conclusion: Conducting risk assessment peculiar to practices and the facility is a necessity for the successful biosafety system at high-level biosafety laboratories. According to the risk assessment carried out in this study, creating additional risk mitigation at laboratories by the guidance of a risk-averse approach particularly during the COVID-19 pandemic might provide biosafety advantages.